TREM2 and atherosclerosis: Single-cell sequencing studies have revealed macrophage heterogeneity in atherosclerosis, notably identifying a subset of foamy triggering receptor expressed on myeloid cells 2 (TREM2)-expressing macrophages enriched for genes involved in lipid metabolism but displaying a non-inflammatory gene expression signature in murine and human plaques4.